Table 2 Enquiry types and motivations to call for DMARDs versus ROC
|  | All DMARDs (n = 1547) (%) | cDMARD (n = 1269) (%) | bDMARDs (n = 278) (%) | ROC (n = 121,709) (%) |
|---|---|---|---|---|
Enquiry type | ||||
 Side-effects | 25.2†| 27.2†| 15.1†‡ | 19.6 |
 Interaction | 19.4†| 21.9†| 6.5†‡ | 15.1 |
 Risk/Benefit & comparison | 12.1†| 12.5†| 9.7‡ | 8.3 |
 Mechanism / Profile | 9.5†| 8.4 | 15.8†‡ | 7.0 |
 Indication & treatment | 10.5 | 10.5 | 10.8 | 11.9 |
 Dose & administration | 6.0 | 6.7 | 2.5†‡ | 7.9 |
 Efficacy | 3.1 | 2.8 | 5.8†‡ | 2.8 |
 Availability | 3.0 | 1.4 | 11.2†‡ | 2.6 |
 Pregnancy & lactation | 2.9†| 3.1†| 1.8†| 8.6 |
 Cost and PBS access | 2.0 | 0.7 | 8.2†‡ | 1.4 |
 Identification / Formulation | 1.9 | 1.2 | 4.7‡ | 3.4 |
 Stability/Storage/Disposal | 1.3 | 0.6 | 4.7†‡ | 0.9 |
 Abuse and withdrawal | 1.4 | 1.5 | 0.4†| 3.4 |
 Generics | 0.4 | 0.3 | 0.7 | 0.8 |
 Vaccination | 0.7 | 0.7 | 0.7 | 1.9 |
 Outside service brief (e.g. | 0.1 | 0.1 | 0 | 1.5 |
 poisons query) |  |  |  |  |
 Non-medicines issue | 0.6 | 0.5 | 1.1 | 2. |
Motivation to call | ||||
 Inadequate information | 44.0 | 44.0 | 57.7†‡ | 46.6 |
 Second opinion | 23.6 | 23.6 | 18.4†‡ | 23.5 |
 Worrying symptom | 18.8 | 18.8 | 13.4†‡ | 17.8 |
 Conflicting information | 6.9†| 6.9†| 1.7†‡ | ~ 0 |
 Information overload | 2.3 | 2.3 | 1.7 | 1.2 |
 CMI | 0.9 | 0.9 | 0.1 | 0.5 |
 Forgot information | 0.7 | 0.7 | 1.3 | 0.1 |
 Media | 1.2 | 1.2 | 3.4†‡ | 0.9 |
 Health professionals | 0.5 | 0.5 | 0.8 | 6.3 |
 Other | 1.1 | 1.1 | 1.7 | 1.7 |